Mittwoch, 8. Mai 2024
Navigation öffnen
Anzeige:
Wefra Programatic
 
JOURNAL ONKOLOGIE – STUDIE
PosESS

Semi-sitting Versus Supine Position in Endoscopic Skull Base Surgery

Rekrutierend

NCT-Nummer:
NCT04584866

Studienbeginn:
Januar 2021

Letztes Update:
02.11.2023

Wirkstoff:
-

Indikation (Clinical Trials):
Adenoma, Pituitary Neoplasms, Pituitary Diseases

Geschlecht:
Alle

Altersgruppe:
Erwachsene (18+)

Phase:
-

Sponsor:
University Hospital, Basel, Switzerland

Collaborator:
-

Studienleiter

Jonathan Rychen
Principal Investigator
Department of Neurosurgery, University Hospital Basel

Kontakt

Michel Röthlisberger, Dr. med.
Kontakt:
Phone: +41 61 328 54 48
E-Mail: Michel.Roethlisberger@usb.ch
» Kontaktdaten anzeigen

Studienlocations
(1 von 1)

Department of Neurosurgery, University Hospital Basel
4031 Basel
SwitzerlandRekrutierend» Google-Maps
Ansprechpartner:
Jonathan Rychen, Dr. med.
Phone: +41 61 328 51 84
E-Mail: Jonathan.Rychen@usb.ch

Michel Roethlisberger, Dr. med.
Phone: +41 61 328 54 48
E-Mail: Michel.Roethlisberger@usb.ch
» Ansprechpartner anzeigen

Studien-Informationen

Detailed Description:

The endonasal endoscopic approach (EEA) for pituitary surgery is standardly performed with

the patient in supine position (SP). The semi-sitting position (SSP) is routinely used for

the traditional microscopic transsphenoidal approach and also for posterior fossa surgery.

The SSP results in lower intracranial pressure when compared to the supine position due to

decreased venous congestion. As a result, intraoperative bleeding may be reduced, potentially

leading to decreased surgical morbidity and improved surgical workflow. Studies during

endoscopic sinus surgery have shown a significant reduction of blood loss when the patient is

placed in a reverse Trendelenburg position with a head elevation of 30°. This study is to

prospectively compare the standard supine (control group) and the semi-sitting position (head

elevation of 30°; intervention group) in endoscopic endonasal pituitary surgery.

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Patients with a presumed pituitary pathologies who are suitable for endoscopic

endonasal surgical resection

Exclusion Criteria:

- Patients with known hemorrhagic or thrombophilic disorders

- Patients with conditions associated with high central venous pressure: congestive

heart failure, pulmonary hypertension, chronic obstructive pulmonary disease (COPD),

interstitial lung disease, pregnancy

- Patients with poor cardiopulmonary condition (unable to perform 4 metabolic

equivalents without stopping (climb a flight of stairs))

Studien-Rationale

Primary outcome:

1. Intraoperative blood loss (Time Frame - Intraoperative):
Intraoperative blood loss, calculated as follow: volume in the suction bag minus volume of rinsing water in Milliliters (ml). The surgery is divided into four steps: 1. endonasal phase, 2. osteodural exposure. 3. sellar stage and 4. skull base defect closure. For each step, the primary outcome will be assessed.

2. Frequency of interruption of the surgical workflow due to disturbing blood or a bleeding in the surgical field (number) (Time Frame - During surgery):
Frequency of interruption of the surgical workflow due to disturbing blood or a bleeding in the surgical field. This will be assessed by an independent blinded neurosurgeon, who will watch the operative video after the surgery.

Secondary outcome:

1. Change in intraoperative Mean Arterial Pressure (MAP) (Time Frame - Intraoperative):
MAP will be monitored during the whole surgery using the software Copra ©, which allows a continuous data extraction

2. Amount of intravenous fluid administered during surgery (ml) (Time Frame - Intraoperative):
Amount of intravenous fluid administered during surgery (ml)

3. Need for vasoactive drugs (vasopressors) (number) (Time Frame - at Day 1 (day of surgery)):
Need for vasoactive drugs (vasopressors) (number)

4. Incidence of air embolism (number) (Time Frame - at Day 1 (day of surgery)):
Incidence of air embolism (number)

5. Operative time (minutes) (Time Frame - During surgery):
Operative time (minutes)

6. Degree of descent or prolapse of the diaphragma sellae into the sellar cavity (Time Frame - Intraoperative):
Intraoperative assessment of the degree of descent or prolapse of the diaphragma sellae into the sellar cavity (class I to V, according to the classification of Abdelmaksoud et al)

7. Occurrence of a cerebrospinal fluid (CSF) leak during surgery (assessed by the operating neurosurgeon) (yes/ no) (Time Frame - During surgery):
Occurrence of a cerebrospinal fluid (CSF) leak during surgery (assessed by the operating neurosurgeon)

8. Surgical ergonomics (Time Frame - at Day 1 (day of surgery)):
Surgical ergonomics assessed by the means of a standardized questionnaire. The surgeon will be asked to rate the intensity of neck and arm discomfort and the frequency of surgical flow interruption due to a suboptimal trajectory of the endoscope and the instruments due to the patient Position (1 = no discomfort, 2 = medium discomfort, 3 = high discomfort).

9. Incidence of rhinoliquorrhoea (number) (Time Frame - at 3 months after surgery):
Incidence of rhinoliquorrhoea (number)

Studien-Arme

  • Active Comparator: Study Intervention
    Endonasal endoscopic pituitary surgery in semi-sitting position
  • Active Comparator: Control Intervention
    Endonasal endoscopic pituitary surgery in supine position

Geprüfte Regime

  • Endonasal endoscopic pituitary surgery in semi-sitting position:
    Patients will be placed in semi-sitting position. To achieve the semi-sitting position, the patient is placed in supine position. The operating table is then separated and flexed to elevate the torso (angle of 30°). The head, which is fixed in a head clamp, is slightly flexed to bring the floor of the sella right in front of the surgeon and gently rotated toward the operating team.
  • Endonasal endoscopic pituitary surgery in supine position:
    Patients will be operated in the standard supine neutral position

Quelle: ClinicalTrials.gov


Sie können folgenden Inhalt einem Kollegen empfehlen:

"Semi-sitting Versus Supine Position in Endoscopic Skull Base Surgery"

Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.

Die mit (*) gekennzeichneten Angaben müssen eingetragen werden!

Die Verwendung Ihrer Daten für den Newsletter können Sie jederzeit mit Wirkung für die Zukunft gegenüber der MedtriX GmbH - Geschäftsbereich rs media widersprechen ohne dass Kosten entstehen. Nutzen Sie hierfür etwaige Abmeldelinks im Newsletter oder schreiben Sie eine E-Mail an: rgb-info[at]medtrix.group.